Neurofibromatosis Type 2 Market Insight, Epidemiology And Market Forecast - 2034The Neurofibromatosis Type 2 treatment market is experiencin ...

Dr. Ivan Baines of the Nick Gilbert Neurofibromatosis Research Institute and Dr. Steven Kalkanis of Henry Ford Health appear ...

BrightSpring Health Services Inc. (NASDAQ:BTSG) is one of the best new stocks to buy now. On June 18, BrightSpring Health ...

Nicole Yelland designed an athletic shoe with a gold sole called La Reina. Sales profits go to expanding homeownership among ...

Edward, now going by the name Guy, appears to be living a much happier life, though this is all upended with the arrival of ...

Neurofibromatosis Type 1 (NF1) is a genetic disorder characterised by benign tumours and cutaneous lesions, including neurofibromas. This case report describes a boy in his early 10s with NF1 who ...

Sarcoma Awareness Month sheds light on rare cancers, emphasizing early detection, research advancement, and patient support.

Ogsiveo (nirogacestat) is approved by the Food and Drug Administration (FDA) for adults with progressing desmoid tumours requiring systemic treatment. The European Medicines Agency’s (EMA) Committee ...

The transaction, finalized following regulatory clearance, includes two FDA-approved rare tumor therapies: Ogsiveo for ...

In June 2025, Novartis Pharmaceuticals conducted a study to assess long-term effect in pediatric patients treated with ...

The streets of downtown Warren will come alive as Wicked Warren’s and the Jefferson DeFrees Family Center team up to host the second annual Freedom Fundraiser 5K Run/Walk and Kids Dash on Saturday.